drug
NX-1607
Phase 1updated 6mo agoby $NRIX Nurix Therapeutics, Inc.
Phase 1community read0 votes
indications
indications
NSCLCDLBCL
all catalysts(0)
nothing on the calendar yet
Trials studying NX-1607
News(2)
- Sanofi scraps STAT6 degrader from Nurix just 2 months after entering clinicSanofi has decided to end work on a STAT6 degrader from Nurix just two months after taking the inflammatory disease drug into the clinic.fiercebiotech · 15d ago
- Nurix drops one BTK degrader as momentum builds behind Roche-partnered optionNurix’s BTK degrader zelebrudomide may have survived a clinical hold in recent years, but that hasn’t stopped the California biotech from dropping the cancer drug.fiercebiotech · 1mo ago
Data sources
last refreshed 2h ago
Found something off?
comments(0)
5-min edit window · permanent after that